SSelectStock

LAXMIDENTLLaxmi Dental Limited

Healthcare · Medical Instruments & Supplies · NSE · as of 2026-09-11 (delayed ~30 min in market hours)

Laxmi Dental Limited manufactures and sells dental products in India, the United States, the United Kingdom, and internationally. It offers custom-made crowns, bridges, clear aligners, thermoforming sheets, and aligner related products, and pediatric dental products. The company serves dental clinics, dental companies, and dentist. The company was incorporated in 2004 and is based in Mumbai, India.

202.84
0.14%
46Average

Mkt Cap
₹1,115 Cr
P/E
36.2
P/B
4.6
Div Yield
0.00%
52W High
₹377.05
52W Low
₹155.88

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)1,114.60
P/E36.16
P/B4.57
PEG1.58
ROE %11.90
ROCE %10.70
Debt / Equity0.05
EPS5.61
Revenue Growth %13.90
Profit Growth %23.00
Dividend Yield %0.00
Promoter Holding %68.16
FII Holding %17.04
DII Holding %
Beta1.40

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals

None of the 16 pattern scanners currently detects a setup on LAXMIDENTL — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.

AVOIDConviction 58%

Why avoid

  • Risk gate: safety score is only 26/100 — volatility, drawdown or liquidity is too poor for a buy call, whatever the chart says
  • ROCE: 10.7%
  • Dividend yield: 0.00%
  • Price vs SMA50: below
  • Price vs SMA200: below

Bull case

  • Profit growth: 23.0% YoY
  • Debt/Equity: 0.05
  • Promoter holding: 68.2%
  • MACD: bullish

Bear case

  • ROCE: 10.7%
  • Dividend yield: 0.00%
  • Price vs SMA50: below
  • Price vs SMA200: below

Key risks

  • Elevated volatility / drawdown profile — size positions accordingly
  • Momentum is fading versus the broader market
  • ROCE: 10.7%
  • Dividend yield: 0.00%

Algorithmic analysis for research only — not SEBI-registered investment advice.

Trade Plan

Entry (CMP)
₹202.84
Stop Loss
₹187.71
risk 7.5%
Target 1 (1.5R)
₹225.53
+11.2%
Target 2 (3R)
₹248.22
+22.4%
Support (20d)
₹189.45
Resistance (52w)
₹377.05
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹15.13/share
ATR (volatility)
₹6.05
avg daily range

Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹6.05). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.

Score Breakdown

Fundamental70
Technical40
Momentum35
Risk (safety)26

Peers — Healthcare

GKSL 1.23%
79
NEPHROPLUS 2.42%
74
KOVAI 1.41%
73
SAILIFE 0.38%
73
METROPOLIS 1.70%
73
VIJAYA 0.21%
72